List view / Grid view
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
Presenting issues and real-life examples within the RNA space, SMi welcome insights and discussions into new technologies for single-stranded RNA, epigenetics to develop first-in class drugs in oncology, patenting RNA Therapeutics and exploring the latest developments in delivery systems, including Exosomes and Nanocomplexes. Read on for your exclusive discount to…
Scientists have rebuilt adenoviruses so that they effectively recognise and infect tumour cells.
Researchers in Spain have developed a method of gene therapy that cures pulmonary fibrosis in mice by lengthening telomeres – the protective protein sections at the end of chromosomes.
Corning to unveil new product offerings at Cell & Gene Therapy World in Miami, Fla.
FDA approves Luxturna for patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy.
Researchers use CRISPR-Cas9 to target a mutation in the Tmc1 gene that causes the loss of hair cells in the inner ear.
A cure for haemophilia is one step closer, following results of a gene therapy trial led by the NHS in London.
Charles River Laboratories International, Inc. announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.
SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018!
Researchers have tested whether a single injection of the gene, LeXis could slow down the development of heart disease...
A leading gene and cell therapy group has announced a collaboration focusing on gene and cell therapy manufacturing..
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease...
Researchers have used CRISPR to stop the expression of individual genes in cancer cells, by knocking out every known protein-encoding gene in the human genome...
"Well thought through and brilliantly executed" study shows different DNA-repair mechanism in embryos compared to iPSCs
